The Medical Research Network (MRN), is a well established clinical research site, which focuses primarily on psychiatric, neurological, and chronic pain disorders. Since our inception in 1997, we have completed numerous phase II, III, and IV studies in depression, panic disorder, generalized anxiety disorder, social anxiety disorder, post-traumatic stress disorder, as well as a variety of neuropathy and chronic pain conditions. MRN was founded by and continues to be directed by Dr. Michael R. Liebowitz, an internationally renowned physician and researcher.

The programs MRN offers are developed to find the best and most effective treatments for people who suffer from depression, anxiety, neurological disorders, and chronic pain disorders.  All of the treatments we offer are provided by specialists in these areas.  MRN specializes in the pharmacology or medication management of these disorders.

MRN also conducts placebo-controlled clinical trials or research studies with medications ranging from marketed anxiolytics and antidepressants to newer, recently developed, or investigational medications which are not yet available to the general public.  MRN's work is sponsored by well known pharmaceutical companies such as AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Novartis, and Pfizer.